Many medical decisions exist in a “grey zone,” where the best choice differs depending on how patients weigh the benefits and risks. A common example is the decision of whether to initiate a more aggressive treatment when simpler therapies fail to control moderate or severe symptoms, such as
No takes yet. Share an insight, caveat, or question.
Annette M. O’Connor (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: